SAB Biotherapeutics
Christoph Bausch has extensive experience in the life sciences industry, holding various roles such as Director of Business Development and Founder/Director of a molecular diagnostics company. Christoph is currently the Executive Vice President & Chief Operating Officer at SAb Biotherapeutics, overseeing research and biomanufacturing operations. With a Ph.D. in Microbiology and an MBA in Entrepreneurship, Christoph is well-versed in both scientific and business aspects of the industry.
SAB Biotherapeutics
SAB Biotherapeutics is advancing a new class of immunotherapies with targeted, fully human polyclonal antibodies for the treatment of Covid-19, diabetes, organ transplant & flu.